International Collaboration

German Center for Neurodegenrative Diseases (DZNE, Munich):
https://www.dzne.de/en/sites/munich.html

The collaboration with DZNE, Munich is coordinated through Translational Neurodegeneration Department. For five years MERC and DZNE has been involved in DAAD funded projects to characterize genetic and epidemiological factors controlling Parkinson’s disease.


Department of Pharmacology and Cancer Biology, Duke University Medical Center:
http://pcb.duke.edu/

For about four years, MERC in collaboration with Pharmacology and Cancer Biology, Duke University, are trying to develop new biomarkers for diagnosis of brain damage. The collaboration has been generously funded by IBRO, ISN, Mansoura University Competitive Grants Program and Academy of Scientific Research and Technology (ASRT).


Luxembourg Center for Systems Bioscience (LCSB):
http://wwwen.uni.lu/lcsb

LCSB and MERC are currently involved in establishment of a new bioinformatic center and integrated biobank for future application in research in the biomedical field.


Genetic Epidemiology of Parkinson’s Disease (GEoPD):
http://geopd.can.ubc.ca/

MERC is currently the newest member of GeoPD and is considered the first member in the Middle East. The main goal of this collaboration is to identify novel environmental and genetic risk factors for PD in Africa.


Department of Neurosciences, Biomedicine and Movement sciences, Universita di Verona, ITALY:
http://www.dsnm.univr.it/?ent=home&page=dipartimento

MERC and DNBM, VERONA is collaborating in promoting the teaching and research in the field of neuroscience.


Department of Chemical Engineering, Northeastern University, USA:
http://www.che.neu.edu/che/about-chemical-engineering

This collaboration aims to explore the possibility of applying nanotechnology in regenerative Medicine.